companydata.dkPharmaforce ApS: Financial statements 2024
CVR: 26394198
Pharmaforce ApS (CVR 26394198) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 5,437,134 and a net result of DKK 1,494,355 compared with DKK 262,216 the year before. That is an increase of 47.6% compared with the year before. Equity amounted to DKK 3,914,650. The solvency ratio was 63.5%. The company had 4 employees in the financial year.
- Gross Profit
- 5,437,134 kr.
- Profit/Loss
- 1,494,355 kr.
- Equity
- 3,914,650 kr.
- Total Assets
- 6,169,249 kr.
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 5.4 mio. | 1.5 mio. | 3.9 mio. | 4 |
| 2023 | - | 3.7 mio. | 262 t. | 2.9 mio. | 5 |
| 2022 | - | 3.6 mio. | 283 t. | 2.9 mio. | 5 |
| 2021 | - | 4.2 mio. | 367 t. | 2.9 mio. | 5 |
| 2020 | - | 4.3 mio. | 1.1 mio. | 2.5 mio. | 5 |
How creditworthy is Pharmaforce ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
Pharmaforce ApS has published its annual report for 2023. Gross profit came to DKK 3,682,481, and the net result was DKK 262,216.
About Pharmaforce ApS
Pharmaforce ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2001. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Mads Louie Frazier. The company is owned by Pfam Holding ApS. The company has 5 employees. In 2025, the company reported a gross profit of DKK 5,238,511 and a net result of DKK 914,232 compared with DKK 1,494,355 the year before. Equity amounted to DKK 4,328,882.